Zhengye Biotechnology Holding Ltd
For the period ended Jul 21, 2026. Filed Jul 21, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 21, 2026 · Filed Jul 21, 2026
Use the contents to explore the available documents and sections.
Contents
Explanatory Note
Zhengye Biotechnology Holding Limited (the “Company”) issued a press release on July 21, 2026, announcing the Company’s comments in response to recent unusual trading activity in the price and trading volume of its Class A ordinary shares. A copy of this press release is attached hereto as Exhibit 99.1, and is incorporated by reference herein.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.